Senior Medical Science Liaison

Summary

Join Nuvalent, a dynamic early-stage company focused on developing cancer therapies, as a Senior Medical Science Liaison (MSL). Reporting to the Senior Director, US Field Medical Affairs, you will play a pivotal role in building relationships with key opinion leaders (KOLs) and supporting Nuvalent's scientific and medical strategy. This field-based position requires strong medical affairs and oncology experience, along with the ability to operate in a fast-paced environment. You will be responsible for engaging with healthcare professionals, developing territory plans, collaborating with cross-functional teams, and contributing to medical education. Success in this role demands strong leadership, communication, and interpersonal skills. The ideal candidate will be located in the Mid-Atlantic region.

Requirements

• Advanced degree (PhD, PharmD, MD/DO, NP, PA-C or equivalent) in a relevant scientific discipline
• Minimum of 6 years of experience in the pharmaceutical or biotechnology industry
• Minimum of 5 years of relevant clinical experience (Hematology/Oncology, Solid Tumor, Lung Cancer)
• Strong interpersonal, presentation and communication skills and demonstrated ability to work collaboratively in a dynamic, team-oriented environment
• Ability to interpret key scientific data and translate findings to meet educational and research needs
• Highly self-motivated and ability to work autonomously
• Collaborative, team-based approach; ability to network and partner with internal and external stakeholders, including medical thought-leaders and a wide range of healthcare professionals
• Understanding of clinical and regulatory requirements in a field-based medical organization
• Willingness to travel at least 60%

Responsibilities

• Serve as a mentor to other MSLs, fostering their development and enhancing the overall effectiveness of the field medical team
• Lead cross-functional collaborations to inform and shape medical strategy, providing advanced insights from the field to support key decision-making
• Identify, establish, and maintain strong scientific, peer-to-peer relationships with national, regional, and local academic and community opinion leaders and other healthcare providers
• Engage in meaningful, peer-to-peer scientific exchange of medical and scientific information with the oncology community, consistent with the Medical Affairs plan
• Develop and execute territory plans in alignment with Medical Affairs plan
• Provide internal stakeholders with feedback and insights from interactions and discussions with HCPs
• Explore potential new areas of interest to understand unmet needs, how the landscape is evolving, and how Nuvalent products could address unmet needs
• Collaborate with clinical development and clinical operations to identify clinical trial sites/investigators and support patient enrollment in our company’s sponsored clinical trials
• Deliver approved medical/scientific presentations to internal and external stakeholders
• Act as a primary liaison to investigators interested in performing investor-sponsored research (ISR)
• Collaborate with Medical Affairs Strategy to monitor ISR, review study design, and oversee milestone requirements to ensure progression of ISR
• Continuously update own knowledge in treatment strategies, products, unmet medical needs, clinical trials and scientific activities
• Lead the planning and execution of subject matter expert meetings/advisory boards, aligned with the Medical Affairs Strategy
• Collaborate with cross-functional partners on internal projects, external initiatives/projects, and field activities
• Support medical/scientific training of cross functional teams and contribute to external medical education
• Attend and provide scientific support for US Medical Affairs activities and scientific sessions at relevant regional and national congress meetings and communicate insights internally
• Adhere to corporate and healthcare compliance guidance in all activities, including those related to clinical trials, scientific interactions with internal and external groups, and responses to unsolicited requests for medical/scientific information